Department of Surgery, Ajou University School of Medicine, Suwon, Republic of Korea.
Department of Health Services Administration, University of Alabama at Birmingham, AL, USA.
Asian J Surg. 2020 Jan;43(1):265-271. doi: 10.1016/j.asjsur.2019.04.001. Epub 2019 Apr 26.
Rectocele is often associated with chronic constipation. Various surgical techniques have been described to repair rectoceles, but the results vary. The aim of this study was to compare the outcomes of transanal repair (TAR) and transanal repair with posterior colporrhaphy (TAR + PC).
While 44 patients underwent TAR, 49 patients underwent TAR + PC for surgical repair of rectocele. Patients were followed up 3 months post-surgery for anorectal physiological changes. From the entire cohort of patients who underwent the surgical repair, 22 patients who underwent TAR and 25 patients who underwent TAR + PC agreed to participate in the 3-year post-treatment check-up.
Out of the 22 patients who underwent TAR, 3 patients (13.6%) scored more than 15 on the constipation scoring system (CSS), while 1 out of 25 patients who underwent TAR + PC scored more than 15 on the CSS 3 months post-treatment, which is considered as recurrence (p = 0.237). With 7 patients from the TAR group (31.8%) and 2 patients from the TAR + PC group (8.0%) showing recurrence of rectocele at 3-year post-treatment follow-up, this study found that TAR + PC had a much lower rate of recurrence than TAR. Furthermore, TAR + PC was found to be more effective than TAR in terms of rectal sensation, sensory threshold (p = 0.001), and early defecation urge (p = 0.003).
TAR + PC can help alleviate some symptoms by restoring the rectal sensation and improving the rectovaginal septum. It can be inferred that the addition of a simple treatment method can lead to a lower rate of recurrence.
直肠前突常与慢性便秘有关。各种手术技术已被描述用于修复直肠前突,但结果各不相同。本研究旨在比较经肛门修复术(TAR)和经肛门修复术联合后阴道修补术(TAR+PC)的结果。
44 例患者接受 TAR 治疗,49 例患者接受 TAR+PC 治疗直肠前突修补术。术后 3 个月对肛门直肠生理变化进行随访。在接受手术修复的全部患者中,22 例接受 TAR 治疗的患者和 25 例接受 TAR+PC 治疗的患者同意接受 3 年治疗后随访。
在接受 TAR 治疗的 22 例患者中,3 例(13.6%)在便秘评分系统(CSS)上得分超过 15,而在接受 TAR+PC 治疗的 25 例患者中,1 例在治疗后 3 个月 CSS 得分超过 15,被认为是复发(p=0.237)。在 3 年治疗后随访中,TAR 组有 7 例(31.8%)和 TAR+PC 组有 2 例(8.0%)出现直肠前突复发,表明 TAR+PC 的复发率明显低于 TAR。此外,TAR+PC 在直肠感觉、感觉阈值(p=0.001)和早期排便冲动(p=0.003)方面比 TAR 更有效。
TAR+PC 通过恢复直肠感觉和改善直肠阴道隔,可以缓解一些症状。可以推断,添加简单的治疗方法可以降低复发率。